Yu Chih-Teng相关文献与解析，生知库 | 链接生命科学的每一步

Lin, Hsiu-Mei; Shu, Chin-Chung; Chen, Chun-Hao; Chen, Nan-Yu; Yang, Jeng-How; Chen, Chih-Hung; Li, Shih-Hong; Wang, Chih-Liang; Yu, Chih-Teng; Lin, Shu-Min; Kao, Kuo-Chin; Huang, Chung-Chi; Yang, Cheng-Ta; Lu, Jang-Jih; Chiu, Cheng-Hsun; Lai, Hsin-Chih; Wu, Ting-Shu

炎症/感染

发表日期：2025

文献求助收藏

Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma

哮喘患者活化嗜酸性粒细胞mRNA表达与空气污染物暴露的相关性

期刊:Immunity Inflammation and Disease

影响因子:2.7

doi:10.1002/iid3.70065

Lin, Ting-Yu; Chang, Po-Jui; Lo, Chun-Yu; Chuang, Hsiao-Chi; Lee, Chung-Shu; Chang, Chih-Hao; Yu, Chih-Teng; Hsieh, Meng-Heng; Liu, Chien-Ying; Kuo, Chih-Hsi Scott; Lin, Shu-Min

Distribution of antibiotic resistance genes among Staphylococcus species isolated from ready-to-eat foods

从即食食品中分离的葡萄球菌属细菌中抗生素耐药基因的分布情况

期刊:Journal of Food and Drug Analysis

影响因子:3

doi:10.1016/j.jfda.2019.05.003

Wang, Yu-Ting; Lin, Yu-Tzu; Wan, Tsai-Wen; Wang, Der-Yuan; Lin, Hsu-Yang; Lin, Che-Yang; Chen, Yu-Chih; Teng, Lee-Jene

微生物学

发表日期：2019

文献求助收藏

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB

更正：S100A9+ MDSC 和 TAM 介导的肺腺癌 EGFR-TKI 耐药性：RELB 的作用

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.25943

Feng, Po-Hao; Yu, Chih-Teng; Chen, Kuan-Yuan; Luo, Ching-Shan; Wu, Shen Ming; Liu, Chien-Ying; Kuo, Lu Wei; Chan, Yao-Fei; Chen, Tzu-Tao; Chang, Chih-Cheng; Lee, Chun-Nin; Chuang, Hsiao-Chi; Lin, Chiou-Feng; Han, Chia-Li; Lee, Wei-Hwa; Lee, Kang-Yun

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations

对于携带有利表皮生长因子突变的原发性肺腺癌患者，比较阿法替尼（Giotrif）40 mg 与剂量递减至 40 mg 以下作为一线治疗的疗效

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.18746

Liu, Chien-Ying; Wang, Chih-Liang; Li, Shih-Hong; Hsu, Ping-Chih; Chen, Chih-Hung; Lin, Ting-Yu; Kuo, Chih-Hsi; Fang, Yueh-Fu; Ko, How-Wen; Yu, Chih-Teng; Yang, Tai-Yun; Yang, Cheng-Ta

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions

对于携带有利突变且靶肺肿瘤得到控制的原发性肺腺癌患者，持续使用表皮生长因子受体酪氨酸激酶抑制剂不会影响生存获益，即使出现新的小病灶。

期刊:Biomedical Journal

影响因子:4.4

doi:10.1016/j.bj.2015.07.002

Hsu, Ping-Chih; Chiu, Li-Chung; Li, Shih-Hong; Chen, Chih-Hung; Wang, Chih-Liang; Kao, Kuo-Chin; Chang, John Wen-Chang; Wang, Chih-Wei; Yu, Chih-Teng; Chung, Fu-Tsai; Yang, Cheng-Ta; Liu, Chien-Ying

Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer

中西医结合治疗对肺癌患者预后的长期疗效

期刊:Journal of Alternative and Complementary Medicine

影响因子:2.3

doi:10.1089/acm.2015.0214

Tang, Woung-Ru; Yang, Sien-Hung; Yu, Chih-Teng; Wang, Chin-Chou; Huang, Sheng-Teng; Huang, Tzu-Hsin; Chiang, Ming-Chu; Chang, Yue-Cune

The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint

从计算机断层扫描角度探讨肺静脉在癌症进展中的作用

期刊:Journal of Oncology

影响因子:

doi:10.1155/2016/1872627

Liaw, Chuang-Chi; Chang, Hung; Liao, Tzu-Yao; Wen, Ming-Sheng; Yu, Chih-Teng; Juan, Yu-Hsiang

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

化疗和EGFR-TKI治疗顺序对不同EGFR突变型肺腺癌的影响

期刊:Biomed Research International

影响因子:2.3

doi:10.1155/2015/948267

Chung, Fu-Tsai; Ho, Ming-Yun; Fang, Yueh-Fu; Hshieh, Meng-Heng; Wang, Tsai-Yu; Kuo, Chih-Hsi; Chen, Hao-Cheng; Wang, Chun-Hwa; Lin, Shu-Min; Yu, Chih-Teng; Lin, Horng-Chyuan; Kuo, Han-Pin

Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer

循环中组织因子阳性微囊泡水平升高与肺癌远处转移相关

期刊:Journal of Cancer Research and Clinical Oncology

影响因子:2.8

doi:10.1007/s00432-013-1544-8

Tseng, Jo-Chi; Chang, Liang-Che; Jiang, Boy-Yiing; Liu, Yu-Chih; Chen, Hung-Jie; Yu, Chih-Teng; Hua, Chung-Ching

Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan

台湾肺部感染中分离出的鸟分枝杆菌复合群菌种的异质性

Correlation Between mRNA Expression of Activated Eosinophils and Air Pollutant Exposure in Patients With Asthma

哮喘患者活化嗜酸性粒细胞mRNA表达与空气污染物暴露的相关性

Distribution of antibiotic resistance genes among Staphylococcus species isolated from ready-to-eat foods

从即食食品中分离的葡萄球菌属细菌中抗生素耐药基因的分布情况

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB

更正：S100A9+ MDSC 和 TAM 介导的肺腺癌 EGFR-TKI 耐药性：RELB 的作用

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations

对于携带有利表皮生长因子突变的原发性肺腺癌患者，比较阿法替尼（Giotrif）40 mg 与剂量递减至 40 mg 以下作为一线治疗的疗效

Continuous epidermal growth factor receptor-tyrosine kinase inhibitor administration in primary lung adenocarcinoma patients harboring favorable mutations with controlled target lung tumors dose not hinder survival benefit despite small new lesions

对于携带有利突变且靶肺肿瘤得到控制的原发性肺腺癌患者，持续使用表皮生长因子受体酪氨酸激酶抑制剂不会影响生存获益，即使出现新的小病灶。

Long-Term Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Lung Cancer

中西医结合治疗对肺癌患者预后的长期疗效

The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint

从计算机断层扫描角度探讨肺静脉在癌症进展中的作用

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma

化疗和EGFR-TKI治疗顺序对不同EGFR突变型肺腺癌的影响

Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer

循环中组织因子阳性微囊泡水平升高与肺癌远处转移相关